Barclays PLC Lian Bio Transaction History

Barclays PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	SELL	$1.79 - $2.85 $71,549 - $113,920	-39,972 Reduced 64.19%	22,297 $51,000
Q1 2023 May 04, 2023	SELL	$1.57 - $2.66 $104,340 - $176,780	-66,459 Reduced 51.63%	62,269 $122,000
Q4 2022 Feb 13, 2023	SELL	$1.14 - $2.11 $159,226 - $294,707	-139,672 Reduced 52.04%	128,728 $211,000
Q3 2022 Nov 03, 2022	BUY	$1.87 - $3.0 $501,908 - $805,200	268,400 New	268,400 $537,000

1.1M

Ticker LIAN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 108,354,000
Market Cap $31.4M
Description
LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with p...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.